Literature DB >> 24781366

Involvement of the family physician in the care of chemotherapy-treated patients with cancer: patients' perspectives.

Eytan Ben-Ami1, Hadar Merom1, Fabienne Sikron1, Jessica Livneh1, Siegal Sadetzki1, Ido Wolf2.   

Abstract

PURPOSE: Increasing numbers of patients receive active ambulatory oncology treatment over prolonged periods of time. Many of these patients suffer from additional comorbidities and require comprehensive medical care. We aimed to assess the perception of patients with cancer regarding the role of the family physician and the oncologist in their care during times of active cancer treatment. PATIENTS AND METHODS: A survey was conducted among 265 consecutive chemotherapy-treated patients at the daycare oncology clinic.
RESULTS: All the patients were affiliated with one of four Israeli health maintenance organizations, 96% had a regular family physician, and 70% had met with him during the preceding month. Only one third of the patients thought their family physician was trained to or was willing to treat medical problems that occurred during chemotherapy treatment. Yet most patients, irrespective of clinical or socioeconomic variables, stated that involvement of the family physician was important to them. Only 30% stated that the oncologist communicated with the family physician. Accordingly, 72% of the patients stated that in the case of an urgent problem they would turn first to the oncology clinic; only 9% would consult their family physician.
CONCLUSIONS: Our data point to a lack of communication between team members and inadequate medical training as major barriers for comprehensive medical care for chemotherapy-treated patients with cancer. Communication between treating teams may improve medical care for oncology patients with multiple treating practitioners.
Copyright © 2014 by American Society of Clinical Oncology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24781366     DOI: 10.1200/JOP.2013.001182

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  8 in total

1.  Identification of health care needs of long-term breast cancer survivors among Israeli women.

Authors:  Lori Mandelzweig; Angela Chetrit; Tova Amitai; Bernice Oberman; Nava Siegelmann Danieli; Barbara Silverman; Siegal Sadetzki
Journal:  Support Care Cancer       Date:  2015-07-21       Impact factor: 3.603

2.  The role of the general practitioner in cancer care: a survey of the patients' perspective.

Authors:  V Lang; S Walter; J Fessler; M J Koester; D Ruetters; J Huebner
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-10       Impact factor: 4.553

Review 3.  The role of the GP in follow-up cancer care: a systematic literature review.

Authors:  Judith A Meiklejohn; Alexander Mimery; Jennifer H Martin; Ross Bailie; Gail Garvey; Euan T Walpole; Jon Adams; Daniel Williamson; Patricia C Valery
Journal:  J Cancer Surviv       Date:  2016-05-02       Impact factor: 4.442

4.  Characteristics and outcome of unplanned hospital admissions in patients with lung cancer: a longitudinal tertiary center study. Towards a strategy to reduce the burden.

Authors:  Kristof Cuppens; Christel Oyen; Aurélie Derweduwen; Anouck Ottevaere; Walter Sermeus; Johan Vansteenkiste
Journal:  Support Care Cancer       Date:  2016-01-27       Impact factor: 3.603

5.  Analysis of nurse navigators' activities for hospital discharge coordination: a mixed method study for the case of cancer patients.

Authors:  Fatima Yatim; Paula Cristofalo; Marie Ferrua; Anne Girault; Marilene Lacaze; Mario Di Palma; Etienne Minvielle
Journal:  Support Care Cancer       Date:  2016-11-09       Impact factor: 3.603

6.  A Cancer Patient Journey: Complete Review During Acute Treatment Phase.

Authors:  Saima Siddiqui; Inez Cruz
Journal:  Health Equity       Date:  2019-08-12

7.  General practitioners' involvement during survivorship care of colon cancer in the Netherlands: primary health care utilization during survivorship care of colon cancer, a prospective multicentre cohort study.

Authors:  Laura A M Duineveld; Hanneke Molthof; Thijs Wieldraaijer; Anthony W H van de Ven; Wim B Busschers; Henk C P M van Weert; Jan Wind
Journal:  Fam Pract       Date:  2019-11-18       Impact factor: 2.267

8.  A developed model of cancer patients participation in intravenous chemotherapy safety.

Authors:  Zeng Na; Yan Qiaoyuan; Wang Binghan; Zhu Qin; Chen Yue; Peng Xin; Tan Cuilian; Yao Cheng
Journal:  Oncotarget       Date:  2017-09-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.